Atlas Trials

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

Clinical trial NCT06617312 · RECRUITING

Trial details

NCT number
NCT06617312
Sponsor
University of California, Los Angeles
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Smoking CessationTobacco Use Disorder
Start date
2024-12-05
Primary completion
2026-12-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.